They are not unique to Glp-1 agonists
There's very little we know about using these hybrid closed-loops in type 2 diabetes
Starting low and adjusting In general terms, initial dosing tends to start at the lower end of an established range to assess tolerability, with any adjustment directed by the provider based on response and side-effect profile
The brokerage estimates Indias weight-loss market at about $500 million, which could rise to $1 billion with the right pricing, adoption and government incentives. Generic drugmakers are also experimenting with a range of delivery formats, including single-use pre-filled syringes, single-shot pen injectors, vials, and reusable pens with adjustable dosing, the people familiar with the matter said
Imaki et al
These data show that LPL remains active on lipoproteins after removal from GPIHBP1 and continues to hydrolyze triglycerides until they are depleted